DAPSONE AGRANULOCYTOSIS IN A LEPROSY PATIENT

Citation
S. Hiran et al., DAPSONE AGRANULOCYTOSIS IN A LEPROSY PATIENT, Leprosy review, 65(3), 1994, pp. 279-281
Citations number
14
Categorie Soggetti
Tropical Medicine",Pathology,"Dermatology & Venereal Diseases
Journal title
ISSN journal
03057518
Volume
65
Issue
3
Year of publication
1994
Pages
279 - 281
Database
ISI
SICI code
0305-7518(1994)65:3<279:DAIALP>2.0.ZU;2-6
Abstract
Dapsone-induced agranulocytosis is a rare adverse effect. There are va rious reports of agranulocytosis in patients treated with dapsone for malaria prophylaxis and other dermatological diseases. However, this a dverse reaction in leprosy is not often encountered. We describe agran ulocytosis in a young patient who was taking dapsone (100 mg) for bord erline-tuberculoid leprosy in a rural environment.